ASX - By Stock
|
AVR |
Re:
Ann: Notice of Annual General Meeting - Withdrawal of Resolution
|
|
Leppo67
|
6 |
1.7K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
6
|
1.7K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Leppo67
|
93 |
27K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
93
|
27K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Leppo67
|
93 |
27K |
7 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
93
|
27K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
Leppo67
|
35 |
10K |
6 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
35
|
10K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
First VIV in Europe! Great outcome.
|
|
Leppo67
|
35 |
10K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
35
|
10K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
AGM 2024 questions - please submit here.
|
|
Leppo67
|
93 |
27K |
12 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
93
|
27K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Leppo67
|
43 |
12K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
43
|
12K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Leppo67
|
43 |
12K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
43
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Leppo67
|
43 |
12K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
43
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Cap Raise - Nasdaq listing
|
|
Leppo67
|
27 |
7.9K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
27
|
7.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
What’s next???
|
|
Leppo67
|
17 |
7.5K |
6 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
17
|
7.5K
|
6
|
|
ASX - By Stock
|
AVR |
What’s next???
|
|
Leppo67
|
17 |
7.5K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
17
|
7.5K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
Leppo67
|
21 |
5.3K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
21
|
5.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
Leppo67
|
21 |
5.3K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
21
|
5.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
Leppo67
|
21 |
5.3K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
21
|
5.3K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
Leppo67
|
91 |
27K |
5 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
27K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
Leppo67
|
37 |
14K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Leppo67
|
200 |
57K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
57K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Leppo67
|
200 |
57K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
200
|
57K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
Leppo67
|
66 |
20K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
Leppo67
|
66 |
20K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Short Sold
|
|
Leppo67
|
8 |
2.3K |
1 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Leppo67
|
40 |
13K |
6 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
40
|
13K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
ozaki procedure
|
|
Leppo67
|
8 |
2.8K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
8
|
2.8K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
Leppo67
|
73 |
27K |
0 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
73
|
27K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Eureka report
|
|
Leppo67
|
56 |
19K |
10 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
56
|
19K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Eureka report
|
|
Leppo67
|
56 |
19K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
56
|
19K
|
0
|
|
ASX - By Stock
|
AVR |
Eureka report
|
|
Leppo67
|
56 |
19K |
11 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
56
|
19K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Abbott pulls trifecta heart valve
|
|
Leppo67
|
15 |
5.3K |
7 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
15
|
5.3K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR first successful implantation Valve-in-Valve
|
|
Leppo67
|
29 |
9.3K |
0 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
29
|
9.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification of cessation of securities - AVR
|
|
Leppo67
|
1 |
742 |
5 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1
|
742
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
Leppo67
|
37 |
14K |
5 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
37
|
14K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Price
|
|
Leppo67
|
37 |
14K |
5 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
37
|
14K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Latest Patient Group Show Best Results to Date at 30 Days
|
|
Leppo67
|
107 |
36K |
4 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
107
|
36K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
EuroPCR2023 - Kicks off with a bang!
|
|
Leppo67
|
32 |
11K |
1 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
32
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Additional Patent for Heart Valve Replacement Technology
|
|
Leppo67
|
6 |
2.3K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
6
|
2.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: $35M Capital Raise
|
|
Leppo67
|
147 |
38K |
3 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
147
|
38K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
The latent value in the Adapt treatment process.
|
|
Leppo67
|
30 |
11K |
1 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
30
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Competitor FDA approval
|
|
Leppo67
|
18 |
8.0K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
18
|
8.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR FIH 30-Day Study Results Presented at TCT Boston
|
|
Leppo67
|
11 |
5.3K |
2 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
11
|
5.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview on Proactive Investors
|
|
Leppo67
|
15 |
6.1K |
0 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
15
|
6.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Talking about TAVR on Sky News this morning In Uk
|
|
Leppo67
|
29 |
12K |
5 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
29
|
12K
|
5
|
|
ASX - By Stock
|
AVR |
Talking about TAVR on Sky News this morning In Uk
|
|
Leppo67
|
29 |
12K |
9 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
29
|
12K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
FDA submission for early feasibility study
|
|
Leppo67
|
64 |
28K |
2 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
64
|
28K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Third Conversion of Securities - Mercer
|
|
Leppo67
|
43 |
18K |
4 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
43
|
18K
|
4
|
|
ASX - By Stock
|
AVR |
Cap raise
|
|
Leppo67
|
0 |
415 |
1 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
0
|
415
|
1
|
|
ASX - By Stock
|
AVR |
Re:
merry xmas and still here
|
|
Leppo67
|
60 |
20K |
8 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
60
|
20K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
merry xmas and still here
|
|
Leppo67
|
60 |
20K |
3 |
26/12/21 |
26/12/21 |
ASX - By Stock
|
60
|
20K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
merry xmas and still here
|
|
Leppo67
|
60 |
20K |
11 |
25/12/21 |
25/12/21 |
ASX - By Stock
|
60
|
20K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First in Human Patient Study Follow Up
|
|
Leppo67
|
57 |
20K |
0 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
57
|
20K
|
0
|
|